The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis
Sun, Yi, Li, Jiejing, Yang, Xiangcai, Zhang, Guiqian, Fan, XinLanguage:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2019.05.003
Date:
May, 2019
File:
PDF, 4.14 MB
english, 2019